˜Dupe That!’, an Invitation to Other Companies to Join the Unicorn Parade to Make Positive Impacts By Investing.com

Bold new campaign spotlights e.l.f.’s FY 2024 Impact Report and progress supporting its intentional efforts to…

Cuba begins to restore power again following another failure By Reuters

By Dave Sherwood HAVANA (Reuters) -Cuba said it was making headway restoring power on Sunday after…

Sanofi to sell 51% stake in Opella to CD&R, 1% to BPI By Reuters

PARIS (Reuters) – France will take a stake in Sanofi (NASDAQ:)’s Opella through the Public Investment…

President Sisi warns regional troubles may force Egypt to re-evaluate IMF accord By Reuters

CAIRO (Reuters) – President Abdel Fattah al-Sisi warned on Sunday Egypt may be forced to re-evaluate…

Moldova holds election, EU vote dogged by alleged Russian meddling By Reuters

By Tom Balmforth and Alexander Tanas CHISINAU (Reuters) -Moldovans voted on Sunday in a presidential election…

Indian retail group seeks antitrust probe of quick commerce companies Swiggy, Blinkit, Zepto By Reuters

By Aditya Kalra NEW DELHI (Reuters) – India’s biggest group of retail distributors has asked the…

Warned by police, some of Canada’s Sikhs feel threatened by India By Reuters

By Anna Mehler Paperny TORONTO (Reuters) -Twice since July 2022, Moninder Singh, spokesperson for a Sikh…

Foresee Pharmaceuticals Announces Preliminary Results from a Phase 1 Clinical Trial, Highlighting Promising Safety, Tolerability and Pharmacokinetic Profile of Linvemastat (FP-020), a Novel and Select

TAIPEI, Oct. 20, 2024 /PRNewswire/ — Foresee Pharmaceuticals (TPEx: 6576), (“Foresee”) today announced the successful completion…

Boeing exploring asset sales to boost finances, WSJ reports By Reuters

(Reuters) – Boeing (NYSE:) is exploring asset sales in a bid to boost its fragile finances…

This time is not different for China, Wells Fargo says By Investing.com

Investing.com — Wells Fargo analysts expressed their skepticism regarding the recent high-profile policy announcements from China, suggesting…